Diabetes Research Centers

Dr. German is the Associate Director and Clinical Director of the UCSF Diabetes Center, Director of the the Hillblom Islet Genesis Network and the UCSF NIH Diabetes Research Center (DRC).
The University of California San Francisco Diabetes Research Center (UCSF DRC) is one of only 16 research centers established by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to accelerate basic and clinical research into diabetes.
Dr. Florez’s research interests lie on the genetic determinants of type 2 diabetes and related metabolic traits, and how these variants may impact disease prediction and therapeutic choices. Thus his laboratory leads two parallel efforts in gene discovery and pharmacogenetics.
The Boston Area Diabetes Endocrinology Research Center is a consortium of laboratory-based and clinical investigators whose efforts are directed toward addressing many of the major research questions bearing on the etiology, pathogenesis, treatment and cure of type 1 and type 2 diabetes.
The Garvey laboratory is interested in the molecular, metabolic, and genetic basis of type 2 diabetes mellitus, insulin resistance, and obesity.
The Diabetes Research and Training Center (DRC) focuses on developing new methods to treat, prevent, and ultimately cure diabetes and its complications.
The purpose of our research is to understand how glucose stimulates insulin secretion by pancreatic islet cells and to characterize and reverse abnormalities in this process that are present in diabetes.
The Vanderbilt Diabetes Research and Training Center (DRTC), is a NIH-sponsored Diabetes Center that facilitates the discovery, application, and translation of scientific knowledge to improve the lives of people with diabetes.
Dr. Myers’ research focuses on the processes that enable the body to respond normally to insulin, and how problems in these pathways contribute to the development of insulin resistance and diabetes.
The goal of the Michigan Diabetes Research Center (MDRC) is to establish, promote, and enhance multidisciplinary and collaborative basic biomedical and clinical research among member investigators studying diabetes, its complications, and related endocrine and metabolic disorders.
My research concerns the molecular mechanisms of type 2 diabetes and the effects of iron on metabolism and risk for chronic diseases. These studies encompass basic mechanistic approaches using animal and cell culture models, as well as multicenter human clinical trials.

The mission of the North Carolina Diabetes Research Center (NCDRC) is to create and support an interactive regional diabetes research community (184 members) across four premiere research institutions in North Carolina, who currently garner over $70 million annually for support of their diabetes

Dr. Shulman is the George R. Cowgill Professor of Medicine, Cellular & Molecular Physiology and Physiological Chemistry at Yale University, where he serves as Co-Director of the Yale Diabetes Research Center and Director of the Yale Mouse Metabolic Phenotyping Center.
The Yale Diabetes Research Center (DRC) was established in the spring of 1993 with the goal of promoting research in diabetes and related metabolic and endocrine disorders at the university.
My background and research are in translational immunology. I am interested in understanding the basis for autoimmune diseases and developing new therapies based on our understanding of disease mechanisms.
The Yale Diabetes Research Center (DRC) was established in the spring of 1993 with the goal of promoting research in diabetes and related metabolic and endocrine disorders at the university.
Clay F. Semenkovich, M.D., is Chief of the Division of Endocrinology, Metabolism and Lipid Research and Professor of Medicine and of Cell Biology and Physiology.
TThe mission of the Washington University School of Medicine (WUSM) Diabetes Research Center (DRC) is to support and enhance research in diabetes and related metabolic diseases.
The main focus of the Sussel lab is to understand the complex transcriptional networks that regulate development, differentiation and function of the pancreas. We have identified several novel regulatory pathways that are essential for islet lineage specification, normal pancreas development and the maintenance of beta cell maturation.
The University of Colorado Denver is world renowned for basic, translational, and clinical diabetes research and treatment of both Type 1 and Type 2 diabetes (T1D and T2D), and their related complications. The University of Colorado Diabetes Research Center will provide improved infrastructure and access to specialized reagents and resources, and an environment that promotes scientific interactions, research discoveries, and progress towards diabetes treatment and cures.
Diabetes Centers

NIDDK Diabetes Centers

NIDDK’s Diabetes Centers program supports extramural research institutions that have established an existing base of high-quality, diabetes-related research. Diabetes Research Centers are part of an integrated program of diabetes and related endocrinology and metabolism research.  Diabetes Research Centers (DRCs) promote new discoveries and enhance scientific progress through the support of cutting-edge basic and clinical research related to the etiology and complications of diabetes, with the goal of rapidly translating research findings into novel strategies for the prevention, treatment and cure of diabetes and related conditions. Centers for Diabetes Translation Research (CDTR) support and enhance type II translation research (e.g., moving from efficacy to testing effectiveness in real world practice and communities and dissemination and implementation science) related to diabetes prevention and treatment.  The CDTRs are intended to enhance the efficiency, productivity, and multidisciplinary nature of diabetes translation research through shared access to specialized technical expertise and resources.